Highlights
- Adherium Limited (ASX:ADR) reported the developments covered below, including operational progress, financial implications and the main outstanding milestones.
- FY26 Revenue rose to AUD 2.100 million from AUD 817,237 in FY25, an increase of 157% YoY.
- Research and development expenditure fell to AUD 2.081 million in FY26 from AUD 3.441 million in FY25.
Adherium Limited (ASX:ADR) reported increased revenue for FY26 as its US remote patient monitoring programme expanded, although the company also recorded a larger annual loss. Its preliminary financial statements for the year ended 30 June 2026 describe a shift away from a primarily research-based structure toward a subscription-supported commercial model. This transition raised income and Investment requirements simultaneously.
Revenue expands after US launch
FY26 revenue rose to AUD 2.100 million from AUD 817,237 in FY25, an increase of 157% YoY. Management linked the improvement to the launch of remote patient monitoring services in the United States. The company provides adherence and inhaler-technique monitoring for a subscription fee. The annual revenue increase is a material development, although the report also notes that patient-onboarding timing influenced the rate at which subscription income developed.
Losses still widened
The net loss attributable to members increased to AUD 14.162 million in FY26 from AUD 12.679 million in FY25. Commercial rollout required additional spending on call-centre and sales teams, engineering, quality assurance, Payroll and contractors. A rising loss alongside strong revenue growth suggests that implementation spending remained high relative to the scale of income. The figures do not yet demonstrate operating profitability or sustainable positive cash flow.
Research spending shifts
Research and development expenditure fell to AUD 2.081 million in FY26 from AUD 3.441 million in FY25. The company attributed this to movement from trials and product development toward commercialisation. Sales and Marketing costs also decreased to AUD 1.804 million from AUD 4.290 million. These reductions should be assessed alongside administrative expense increases rather than interpreted as a uniform decline across the whole cost base.
Administrative expenditure grows
Administration expenses increased to AUD 11.698 million from AUD 5.486 million. The filing associates this with payroll, consulting, capital-raising costs, executive recruitment and the reclassification of some personnel expenses after the New Zealand Facility ceased operations. Reclassifications complicate simple category-by-category comparisons. The overall loss and cash position are therefore essential to evaluating the financial cost of the Business transition.
Liquidity and financial risks
Cash at 30 June 2026 was AUD 1.424 million, compared with AUD 43,255 a year earlier. The filing also highlighted uncertainty surrounding Going Concern until additional funding or operating cash generation supports the group. Higher year-end cash improves immediate resources, but it does not remove the need for adequate finance. The key forward measure is whether remote monitoring subscriptions can grow faster than the costs required to service customers.
For Adherium Limited (ASX:ADR), the distinction between a reported result and an expected future milestone remains important. The financial and operational disclosures cover defined reporting periods, while the timing of further work, receipt of funds and outcomes of planned activities may depend on external approvals or commercial execution. Comparisons are therefore most meaningful when the measurement period, nature of the metric and any outstanding conditions are kept separate. The current position reflects the disclosed facts rather than an assumption that the next project or commercial stage has already been achieved.
Key Insights
Adherium achieved strong reported revenue growth as remote monitoring became a commercial business, but FY26 losses widened and funding remained important. The next test is the relationship between subscriber onboarding, recurring receipts and operating expenditure.






Please wait processing your request...